Methadone Alternative
Sublocade Treatment in Albany, NY
For patients managing opioid use disorder who want the clinical effectiveness of buprenorphine without the demands of daily dosing, Sublocade offers a meaningful clinical advantage. Sublocade is an extended-release, FDA-approved once-monthly injectable form of buprenorphine for opioid use disorder and designed to provide consistent, steady medication levels throughout the month. At Fusion Recovery Center in Albany, NY, Sublocade is available as part of our comprehensive MAT program, integrated with counseling and outpatient programming to support lasting recovery.
What Is Sublocade and How Does It Work?
Sublocade is an extended-release formulation of buprenorphine, the same active ingredient in Suboxone, delivered as a once-monthly subcutaneous injection administered by a healthcare provider. Unlike daily Suboxone films or tablets, Sublocade slowly releases buprenorphine over the course of the month, maintaining consistent therapeutic blood levels without requiring daily patient administration.
Buprenorphine is a partial opioid agonist. It attaches to opioid receptors in the brain and partially activates them, reducing cravings and withdrawal symptoms without producing the intense euphoric high of full opioid agonists. Sublocade delivers this effect continuously and consistently throughout the month, eliminating the fluctuations in medication levels that can occur with daily oral dosing.
Because Sublocade is injected and forms a solid deposit under the skin that slowly dissolves, it cannot be diverted, misused, or self-administered at higher doses. This makes it one of the most misuse-resistant MAT options available.
Sublocade vs. Daily Suboxone: Understanding the Difference
Sublocade and Suboxone both contain buprenorphine and are both effective for opioid use disorder — but they differ significantly in how they are administered and who they are best suited for.
Sublocade
Formulation | Extended-release injection |
Dosing frequency | Once monthly — administered by provider |
Medication levels | Consistent throughout month |
Misuse/diversion risk | Minimal — cannot be self-administered at higher doses |
Compliance | Eliminates missed daily doses |
Best for | Patients with compliance challenges, privacy preferences, or daily dosing burden |
Clinic visits | Monthly injection appointment |
Formulation | Sublingual film or tablet |
Dosing frequency | Daily — self-administered |
Medication levels | Can fluctuate with daily dosing |
Misuse/diversion risk | Low — naloxone deters misuse, but daily supply exists |
Compliance | Requires consistent daily adherence |
Best for | Patients who prefer home-based daily dosing flexibility |
Clinic visits | Prescription refills at prescriber intervals |
Both options are available at Fusion Recovery. Your clinical team will help determine which formulation is most appropriate based on your history, lifestyle, and recovery goals.
What to Expect: Sublocade Treatment at Fusion Recovery
01.
Comprehensive Clinical Evaluation
Your treatment begins with a full clinical evaluation, a physical exam, complete review of your substance use history, mental health screening, and assessment of co-occurring conditions. This evaluation determines whether Sublocade is the most appropriate MAT option for your situation, and shapes your complete treatment plan.
02.
Stabilization on Oral Buprenorphine
Before starting Sublocade, patients must first be stabilized on a daily oral buprenorphine product, typically Suboxone, for a minimum of seven days. This stabilization period ensures that you are tolerating buprenorphine well and have reached a stable therapeutic dose before transitioning to the injectable form. Your physician manages this transition carefully.
03.
First Sublocade Injection
Once stabilized on oral buprenorphine, you receive your first Sublocade injection, administered subcutaneously (under the skin, typically in the abdomen) by a healthcare provider at Fusion Recovery. A gel-like deposit forms under the skin, which slowly releases buprenorphine over the following month. Monthly injections continue on schedule from there.
04.
Monthly Injection Appointments
After your first injection, you return to Fusion Recovery monthly for your ongoing Sublocade dose. These appointments also provide regular clinical contact, an opportunity for your physician and clinical team to monitor your progress, address any concerns, and ensure your treatment plan remains on track.
05.
Counseling and Therapy
Like all MAT at Fusion Recovery, Sublocade treatment is integrated with addiction therapy and counseling, and structured outpatient programming. Medication alone does not address the behavioral and psychological dimensions of recovery, your clinical team coordinates medication management alongside the counseling and therapy that builds lasting sobriety.
The Benefits of Sublocade Treatment
Consistent, stable medication levels
Daily oral buprenorphine can produce fluctuations in blood levels throughout the day, potentially affecting how well cravings and withdrawal are controlled. Sublocade’s extended-release formulation delivers a consistent, steady level of buprenorphine throughout the entire month, providing more stable and reliable symptom control.
Eliminates the daily medication burden
For patients who find daily medication adherence challenging, due to schedule, life circumstances, or the cognitive demands of early recovery, Sublocade removes that daily task entirely. One monthly injection replaces 30 daily doses, significantly simplifying the medication component of treatment.
Virtually eliminates misuse and diversion risk
Because Sublocade is injected and forms a solid subcutaneous deposit that cannot be accessed or self-administered at higher doses, the risk of misuse or diversion is minimal. This is a significant clinical advantage for patients with concerns about medication security, or for prescribers in settings where diversion is a consideration.
Reduces relapse risk from missed doses
One of the most common pathways to relapse in patients on daily oral MAT is missed doses, whether intentional or circumstantial. Sublocade eliminates this risk by providing a month of continuous medication coverage from a single administration.
Privacy and discretion
Monthly clinic visits for an injection appointment are more discreet than daily clinic visits or managing daily medication at home. For patients who value privacy in their treatment, Sublocade offers a less visible medication regimen.
Supports treatment retention
The once-monthly structure of Sublocade creates a built-in rhythm of regular clinical contact, monthly injection appointments that provide consistent touchpoints with the treatment team, supporting engagement and accountability throughout recovery.
Who Is Sublocade Best Suited For?
Sublocade is an excellent option for patients who:
- Patients who have struggled with consistent daily Suboxone adherence, whether due to schedule, life circumstances, or the demands of early recovery, often find that monthly Sublocade injections remove that barrier entirely.
- Monthly injection appointments are less visible than daily clinic visits or managing daily medication at home. For patients who want to maintain their recovery privately, Sublocade’s monthly structure offers meaningful discretion.
- Sublocade requires prior stabilization on oral buprenorphine, making it a natural next step for patients who are already stable on Suboxone and want to transition to a less demanding dosing format.
- For patients who recognize that missed doses represent a significant relapse risk for them personally, Sublocade’s elimination of daily dosing provides a meaningful clinical safeguard.
- Sublocade is indicated for opioid use disorder broadly, including heroin, fentanyl, and prescription opioid dependency, and is particularly valuable for patients managing higher-potency opioid dependencies where consistent medication coverage is clinically critical.
Why Choose Fusion Recovery for Sublocade Treatment?
At Fusion Recovery, Sublocade treatment is delivered within a fully integrated outpatient program, not as a standalone medication service. Here’s what you can expect:
- Board-certified physicians managing Sublocade prescribing, injection, and medical oversight
- Prior stabilization support — clinical management of the oral buprenorphine stabilization period before initiating Sublocade
- Counseling integrated from day one — individual therapy, group therapy, and structured programming alongside medication
- Personalized treatment plans built around your clinical history and recovery goals
- Flexible outpatient scheduling — monthly injection appointments designed around your life
- Non-judgmental, stigma-free environment — compassionate care regardless of history
- OASAS-certified outpatient treatment provider serving Albany and the Capital Region
Start Sublocade Treatment at Fusion Recovery
If you’re interested in Sublocade — or want to understand whether it’s the right MAT option for your situation — our clinical team is here to help. We’ll answer your questions, walk you through the evaluation process, and help you determine the best path forward.
FAQ on Sublocade
01. What is Sublocade?
Sublocade is an FDA-approved, extended-release injectable formulation of buprenorphine used to treat opioid use disorder. It is administered as a once-monthly subcutaneous injection by a healthcare provider, delivering consistent buprenorphine levels throughout the month without requiring daily patient dosing. At Fusion Recovery, Sublocade is available as part of a comprehensive MAT program integrated with counseling and outpatient care.
03. How does Sublocade work?
Sublocade releases buprenorphine gradually from a subcutaneous depot over the course of a month. Buprenorphine is a partial opioid agonist — it binds to opioid receptors and partially activates them, reducing cravings and withdrawal symptoms without producing the intense highs of full opioid agonists. The consistent, steady blood levels from Sublocade provide reliable symptom control throughout the month.
05. Is Sublocade safe?
Yes. Sublocade is FDA-approved and has been through rigorous clinical trials demonstrating its safety and efficacy for opioid use disorder treatment. As with any medication, side effects can occur — common ones include injection site reactions, constipation, nausea, and headache. Your clinical team monitors for side effects throughout treatment and adjusts care as needed.
07. How long does Sublocade treatment last?
The appropriate duration of Sublocade treatment is determined by individual clinical need and recovery goals. There is no preset timeline — many patients benefit from longer-term maintenance. Your clinical team will work with you to determine the right duration and any transition plan when the time comes.
09. Does insurance cover Sublocade treatment?
Most insurance plans, including Medicaid, cover Sublocade as part of substance use disorder treatment. Coverage specifics vary by plan — Fusion Recovery can verify your benefits before your first appointment. Contact our admissions team to confirm your coverage.
02. How is Sublocade different from Suboxone?
Both contain buprenorphine and treat opioid use disorder, but they differ in how they are administered. Suboxone is taken daily as a sublingual film or tablet. Sublocade is injected once monthly by a provider, forming a slow-release depot under the skin. Sublocade eliminates daily dosing, provides more consistent medication levels, and virtually eliminates misuse and diversion risk.
04. Do I need to be on Suboxone before starting Sublocade?
Yes. Sublocade requires prior stabilization on a daily oral buprenorphine product — typically Suboxone — for a minimum of seven days before the first injection. This stabilization period ensures you are tolerating buprenorphine well and have reached a stable therapeutic dose. Your physician at Fusion Recovery will manage this transition.
06. Can Sublocade be misused?
The misuse and diversion risk with Sublocade is minimal. Because it is injected and forms a solid subcutaneous deposit that dissolves slowly, it cannot be self-administered at higher doses, extracted, or diverted in the way that oral medications can. This makes it one of the most misuse-resistant MAT options available.
08. What are the side effects of Sublocade?
Common side effects may include injection site reactions (pain, redness, itching, or a small lump at the injection site), constipation, nausea, headache, fatigue, and insomnia. Most side effects are mild and manageable. Your clinical team will review potential side effects with you before starting treatment and monitor throughout.
10. Is Sublocade right for me?
Sublocade is best suited for patients who are already stable on oral buprenorphine, have compliance challenges with daily dosing, want a more discreet treatment approach, or need the strongest possible protection against missed doses. If you’re not sure whether Sublocade or another MAT option is right for your situation, our clinical team can help you evaluate your options and make an informed decision.
01. What is Sublocade?
Suboxone is an FDA-approved medication containing buprenorphine and naloxone, used to treat opioid use disorder. Buprenorphine is a partial opioid agonist that reduces cravings and withdrawal symptoms; naloxone is an antagonist included to deter misuse. At Fusion Recovery, Suboxone is prescribed as part of a comprehensive MAT program that includes counseling and structured outpatient care.
02. How is Sublocade different from Suboxone?
Both contain buprenorphine and treat opioid use disorder, but they differ in how they are administered. Suboxone is taken daily as a sublingual film or tablet. Sublocade is injected once monthly by a provider, forming a slow-release depot under the skin. Sublocade eliminates daily dosing, provides more consistent medication levels, and virtually eliminates misuse and diversion risk.
03. How does Sublocade work?
Sublocade releases buprenorphine gradually from a subcutaneous depot over the course of a month. Buprenorphine is a partial opioid agonist — it binds to opioid receptors and partially activates them, reducing cravings and withdrawal symptoms without producing the intense highs of full opioid agonists. The consistent, steady blood levels from Sublocade provide reliable symptom control throughout the month.
04. Do I need to be on Suboxone before starting Sublocade?
Yes. Sublocade requires prior stabilization on a daily oral buprenorphine product — typically Suboxone — for a minimum of seven days before the first injection. This stabilization period ensures you are tolerating buprenorphine well and have reached a stable therapeutic dose. Your physician at Fusion Recovery will manage this transition.
05. Is Sublocade safe?
Yes. Sublocade is FDA-approved and has been through rigorous clinical trials demonstrating its safety and efficacy for opioid use disorder treatment. As with any medication, side effects can occur — common ones include injection site reactions, constipation, nausea, and headache. Your clinical team monitors for side effects throughout treatment and adjusts care as needed.
06. Can Sublocade be misused?
The misuse and diversion risk with Sublocade is minimal. Because it is injected and forms a solid subcutaneous deposit that dissolves slowly, it cannot be self-administered at higher doses, extracted, or diverted in the way that oral medications can. This makes it one of the most misuse-resistant MAT options available.
07. How long does Sublocade treatment last?
The appropriate duration of Sublocade treatment is determined by individual clinical need and recovery goals. There is no preset timeline — many patients benefit from longer-term maintenance. Your clinical team will work with you to determine the right duration and any transition plan when the time comes.
08. What are the side effects of Sublocade?
Common side effects may include injection site reactions (pain, redness, itching, or a small lump at the injection site), constipation, nausea, headache, fatigue, and insomnia. Most side effects are mild and manageable. Your clinical team will review potential side effects with you before starting treatment and monitor throughout.
09. Does insurance cover Sublocade treatment?
Most insurance plans, including Medicaid, cover Sublocade as part of substance use disorder treatment. Coverage specifics vary by plan — Fusion Recovery can verify your benefits before your first appointment. Contact our admissions team to confirm your coverage.
10. Is Sublocade right for me?
Sublocade is best suited for patients who are already stable on oral buprenorphine, have compliance challenges with daily dosing, want a more discreet treatment approach, or need the strongest possible protection against missed doses. If you’re not sure whether Sublocade or another MAT option is right for your situation, our clinical team can help you evaluate your options and make an informed decision.
If you’re ready, we’ll listen and help you explore treatment options without pressure.
Take the first step
Providing hope to all. Compassionate outpatient care for our community. Ready to talk?
Recovery begins when you reach out. Questions?
Call anytime to speak with an Admissions
Specialist, or request a consultation and we’ll follow up.
David Sietz, M.D.
Chief Medical Officer, Fusion Recovery
Email us or Call
Contact Form
"(Required)" indicates required fields
